Authors: Bernard, MH Massart, C Werneau, JL Schlienger, JL Mlika-Cabanne, N Blouin, P Bukowski, JV Chupin, M Collignon, I De Boysson, M Isnard, R Jamet, JL Kaloustian, E Mas, JL Massart, C Mira, R Rohmer, V Rousset, H Soulie, P Teslar, E Mlika-Cabanne, N Alix, M Archambeaud, F Aubert, L Baldet, L Beutter, D Caron, P Chabrier, G Chantegreil, F Chapuis, J Cohen-Solal, A Conte-Devoix, B Couplet, G Dany, F Daver, A Doucet, J Dreyfus, M Du Rostu, H Gay, B Giraud, P Gruson, A Gerber, F Guillausseau, C Houlbert, C Kahn, R Lagarde, J Laisne, C Legrand, JL Leveque, M Martinet, C Millet, A Nambotin, P Orgiazzi, J Pochet, P Potier, A Pouget-Abadie, JF Rouanet, G Rymer, JC Sadoul, JL Sapin, R Tardieu, J Thibon, R Vetel, JM Wemeau, JL Winiszewski, P

Citation: Mh. Bernard et al., Laboratory diagnosis and follow-up of adults with hyperthyroidism, ANN ENDOCR, 61(3), 2000, pp. 284-287

Authors: Hubl, W Chan, DW Van Ingen, HE Miyachi, H Molina, R Filella, X Pitzel, L Ruibal, A Rymer, JC Bagnard, G Domke, I

Citation: W. Hubl et al., Multicenter evaluation of the Elecsys (R) CA 125 II assay, ANTICANC R, 19(4A), 1999, pp. 2727-2733

Authors: Rymer, JC Sabatier, R Daver, A Bourleaud, J Assicot, M Bremond, J Rapin, J Salhi, SL Thinion, B Vassault, A Ingrand, J Pau, B

Citation: Jc. Rymer et al., A new approach for clinical biological assay comparison and standardization: Application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits, CLIN CHEM, 45(6), 1999, pp. 869-881

Authors: van Ingen, HE Chan, DW Hubl, W Miyachi, H Molina, R Pitzel, L Ruibal, A Rymer, JC Domke, I

Citation: He. Van Ingen et al., Analytical and clinical evaluation of an electrochemiluminescence immunoassay for the determination of CA 125, CLIN CHEM, 44(12), 1998, pp. 2530-2536

Authors: Rostoker, G Rymer, JC Bagnard, G Petit-Phar, M Griuncelli, M Pilatte, Y

Citation: G. Rostoker et al., Imbalances in serum proinflammatory cytokines and their soluble receptors:a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy?, CLIN EXP IM, 114(3), 1998, pp. 468-476